Discover why KOH equivalence is used to report TBN values and how it ensures consistency across oil condition monitoring ...

Eli Lilly’s oral GLP-1 therapy, orforglipron, met all primary and key secondary endpoints in the Phase III ACHIEVE-2 and ACHIEVE-5 studies, showing significant A1C reduction, weight loss, and ...

Vertanical’s cannabis-based pain reliever, VER-01, has shown superiority over opioids in a Phase III trial.

Viking offers asymmetric upside in GLP-1 drugs with positive trial data, strong cash, and buyout potential despite biotech ...

Learn how FTIR spectroscopy simplifies pharmaceutical formulation by providing rapid, accurate molecular analysis.

Professor Philip Molyneaux will give an oral presentation on the key efficacy and safety results from the Phase 2b CORAL ...

Bristol Myers Squibb has ended its R&D losing streak with a hit on one of the dual primary endpoints in a phase 3 multiple myeloma trial. But with the study continuing to evaluate the other primary ...

Microsoft is working to resolve a bug that causes Defender for Endpoint to incorrectly tag some devices' BIOS (Basic Input/Output System) firmware as outdated, prompting users to update it. In a ...

Investing.com -- Enanta Pharmaceuticals (NASDAQ:ENTA) stock fell 14% after the company announced that its experimental drug zelicapavir failed to meet the primary endpoint in a Phase 2b study for ...

Zoho Corp's homegrown messaging app Arattai has exploded in popularity over the past week, with some thinking it can take on Meta-owned WhatsApp in the Indian market. But amid all the positive chatter ...